yavanna's watchlist [more than 800 articles] Export

Recent papers matching yavanna's watchlist criteria

	BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. [My Copy] The Biochemical journal, Vol. 401, No. 1. (1 January 2007), pp. 29-38. by Gopal P. Sapkota, Lorna Cummings, Felicity S. Newell, et al.Christopher Armstrong, Jennifer Bain, Morten Frodin, Matthias Grauert, Matthias Hoffmann, Gisela Schnapp, Martin Steegmaier, Philip Cohen, Dario R. Alessi posted to rsk inhibitor by guhjy on 2009-11-22 09:45:10 as
	RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. [My Copy] The Journal of biological chemistry, Vol. 282, No. 19. (11 May 2007), pp. 14056-14064. by Philippe P. Roux, David Shahbazian, Hieu Vu, et al.Marina K. Holz, Michael S. Cohen, Jack Taunton, Nahum Sonenberg, John Blenis posted to rsk erk by guhjy on 2009-11-22 09:40:26 as
	Bradykinin and high glucose promote renal tubular inflammation. [My Copy] Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (18 November 2009) by Sydney C. Tang, Loretta Y. Chan, Joseph C. Leung, et al.Amy Shan S. Cheng, Kwok Wah W. Chan, Hui Yao Y. Lan, Kar Neng N. Lai posted to vegf tgfb pt pkc kinin inflammation hg erk by guhjy on 2009-11-22 09:40:11 as
	Effects of a novel RSK inhibitor on α1-adrenergic regulation of myocardial NHE1 [My Copy] Journal of Molecular and Cellular Cardiology, Vol. 42, No. 6. (June 2007), pp. S46-S47. by F. Cuello, A. Snabaitis, M. Cohen, J. Taunton, M. Avkiran posted to rsk inhibitor by guhjy on 2009-11-22 09:34:30 as
	RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility [My Copy] Proceedings of the National Academy of Sciences, Vol. 106, No. 23. (9 June 2009), pp. 9268-9273. by Michelle D. Larrea, Feng Hong, Seth A. Wander, et al.Thiago G. da Silva, David Helfman, Deborah Lannigan, Jeffrey A. Smith, Joyce M. Slingerland posted to rsk rho p27 1 by guhjy on 2009-11-22 09:33:03 as
	The versatile role of MSKs in transcriptional regulation. [My Copy] Trends in biochemical sciences, Vol. 34, No. 6. (June 2009), pp. 311-318. by Linda Vermeulen, Wim Vanden V. Berghe, Ilse M. Beck, Karolien De Bosscher, Guy Haegeman posted to msk by guhjy on 2009-11-22 09:32:50 as
	ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15 [My Copy] Proceedings of the National Academy of Sciences, Vol. 104, No. 50. (11 December 2007), pp. 19837-19842. by Hema Vaidyanathan, John Opoku-Ansah, Sandra Pastorino, Hema Renganathan, Michelle L. Matter, Joe W. Ramos posted to rsk erk 1 by guhjy on 2009-11-22 09:32:14 as
	Ribosomal S6 Kinase 2 Is a Key Regulator in Tumor Promoter Induced Cell Transformation [My Copy] Cancer Res, Vol. 67, No. 17. (1 September 2007), pp. 8104-8112. by Yong-Yeon Cho, Ke Yao, Hong-Gyum Kim, et al.Bong S. Kang, Duo Zheng, Ann M. Bode, Zigang Dong posted to rsk cancer by guhjy on 2009-11-22 09:30:22 as
	RSK and MSK in MAP kinase signalling [My Copy] J Cell Sci, Vol. 119, No. 15. (1 August 2006), pp. 3021-3023. by Camilla Hauge, Morten Frodin posted to rsk msk mapk by guhjy on 2009-11-22 09:29:39 as
	Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. [My Copy] Cancer research, Vol. 65, No. 3. (1 February 2005), pp. 1027-1034. by Jeffrey A. Smith, Celeste E. Poteet-Smith, Yaming Xu, Timothy M. Errington, Sidney M. Hecht, Deborah A. Lannigan posted to rsk inhibitor by guhjy on 2009-11-22 09:28:58 as
	A clickable inhibitor reveals context-dependent autoactivation of p90 RSK. [My Copy] Nature chemical biology, Vol. 3, No. 3. (28 March 2007), pp. 156-160. by Michael S. Cohen, Haralambos Hadjivassiliou, Jack Taunton posted to rsk inhibitor by guhjy on 2009-11-22 09:26:16 as along with 1 person kokphinchooi
	Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. [My Copy] Journal of cellular biochemistry, Vol. 104, No. 2. (15 May 2008), pp. 657-667. by Andy T. Lau, Ying Wang, Jen-Fu F. Chiu posted to ros proliferation cancer by guhjy on 2009-11-22 08:53:41 as
	Arrestin Orchestrates Crosstalk Between G Protein-Coupled Receptors to Modulate the Spatiotemporal Activation of ERK MAPK. [My Copy] Circulation research (19 November 2009) by David Cervantes, Catherine Crosby, Yang Xiang posted to gpcr erk arrestin by guhjy on 2009-11-22 08:45:56 as
	G protein-coupled receptors stimulation and the control of cell migration. [My Copy] Cellular signalling, Vol. 21, No. 7. (July 2009), pp. 1045-1053. by Mathieu Cotton, Audrey Claing posted to migration gpcr by guhjy on 2009-11-22 08:45:47 as
	Vascular signaling through G protein-coupled receptors: new concepts. [My Copy] Current opinion in nephrology and hypertension, Vol. 18, No. 2. (March 2009), pp. 153-159. by Masuko Ushio-Fukai posted to nox gpcr by guhjy on 2009-11-22 08:44:17 as
	GPCR signaling: understanding the pathway to successful drug discovery. [My Copy] Methods in molecular biology (Clifton, N.J.), Vol. 552 (2009), pp. 39-50. by Christine Williams, Stephen J. Hill posted to gpcr by guhjy on 2009-11-22 08:43:59 as
	Modeling of G-protein-coupled receptor signaling pathways. [My Copy] The Journal of biological chemistry, Vol. 284, No. 9. (27 February 2009), pp. 5427-5431. by Jennifer J. Linderman posted to gpcr by guhjy on 2009-11-22 08:43:49 as along with 1 person abhishek_tiwari
	Reactive oxygen species as mediators of angiotensin II signaling. [My Copy] Regulatory peptides, Vol. 91, No. 1-3. (28 July 2000), pp. 21-27. by K. K. Griendling, M. Ushio-Fukai posted to ros at1 by guhjy on 2009-11-22 08:38:46 as
	RAS: target for cancer therapy. [My Copy] Cancer investigation, Vol. 26, No. 9. (November 2008), pp. 948-955. by Nandita Saxena, Sitanshu Sekhar S. Lahiri, Shashank Hambarde, Rajendra Prasad P. Tripathi posted to ras cancer by guhjy on 2009-11-22 08:33:50 as
	Discovery of Potent and Selective Inhibitors of the Mammalian Target of Rapamycin (mTOR) Kinase. [My Copy] Journal of medicinal chemistry, Vol. 52, No. 22. (26 November 2009), pp. 7081-7089. by Pawel Nowak, Derek C. Cole, Natasja Brooijmans, et al.Matthew G. Bursavich, Kevin J. Curran, John W. Ellingboe, James J. Gibbons, Irwin Hollander, Yongbo Hu, Joshua Kaplan, David J. Malwitz, Lourdes Toral-Barza, Jeroen C. Verheijen, Arie Zask, Wei-Guo G. Zhang, Ker Yu posted to mtor inhibitor by guhjy on 2009-11-22 08:24:06 as
	Targeting RSK: an overview of small molecule inhibitors. [My Copy] Anti-cancer agents in medicinal chemistry, Vol. 8, No. 7. (October 2008), pp. 710-716. by Tam Luong L. Nguyen posted to rsk inhibitor by guhjy on 2009-11-22 08:23:47 as
	Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR). [My Copy] The Biochemical journal, Vol. 421, No. 1. (1 July 2009), pp. 29-42. by Juan M. García-Martínez, Jennifer Moran, Rosemary G. Clarke, et al.Alex Gray, Sabina C. Cosulich, Christine M. Chresta, Dario R. Alessi posted to mtor inhibitor 1 by guhjy on 2009-11-22 08:18:11 as
	Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products. [My Copy] British journal of pharmacology (16 November 2009) by Chun Liang, Yusheng Ren, Hongbin Tan, et al.Zhiqing He, Qijun Jiang, Jianxiang Wu, Yi Zhen, Min Fan, Zonggui Wu posted to pparg nos epc akt age by guhjy on 2009-11-22 08:02:40 as
	Current perspectives on Akt Akt-ivation and Akt-ions. [My Copy] Experimental biology and medicine (Maywood, N.J.), Vol. 234, No. 11. (November 2009), pp. 1264-1270. by Ronald W. Matheny, Martin L. Adamo posted to rsk mtor akt by guhjy on 2009-11-22 08:01:14 as
	The role of AMP-activated protein kinase in the cardiovascular system. [My Copy] Hypertension research : official journal of the Japanese Society of Hypertension (13 November 2009) by Daisuke Nagata, Yasunobu Hirata posted to cv ampk by guhjy on 2009-11-22 07:59:46 as
	Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. [My Copy] Biochimica et biophysica acta (22 September 2009) by S. Fogarty, D. G. Hardie posted to dm cancer ampk by guhjy on 2009-11-22 07:58:43 as
	Cell signaling. Aging is RSKy business. [My Copy] Science (New York, N.Y.), Vol. 326, No. 5949. (2 October 2009), pp. 55-56. by Matt Kaeberlein, Pankaj Kapahi posted to rsk aging by guhjy on 2009-11-22 07:30:51 as along with 2 people mkotlyar renatomilani
	p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells. [My Copy] Cancer research, Vol. 68, No. 16. (15 August 2008), pp. 6524-6532. by Yuen L. Pon, Hong Y. Zhou, Annie N. Cheung, Hextan Y. Ngan, Alice S. Wong posted to rsk emt cancer by guhjy on 2009-11-22 07:29:03 as
	Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. [My Copy] Molecular and cellular biology, Vol. 23, No. 14. (July 2003), pp. 4796-4804. by Philippe P. Roux, Stephanie A. Richards, John Blenis posted to rsk erk 1 by guhjy on 2009-11-22 07:27:26 as
	Regulation of protein kinase A (PKA) activity by p90 ribosomal S6 kinase 1 (RSK1). [My Copy] The Journal of biological chemistry (5 October 2009) by Xianlong Gao, Tarun B. Patel posted to rsk pka 1 by guhjy on 2009-11-22 06:27:05 as
	Subcellular localization and biological actions of activated RSK1 are determined by its interactions with subunits of cyclic AMP-dependent protein kinase. [My Copy] Molecular and cellular biology, Vol. 26, No. 12. (June 2006), pp. 4586-4600. by Deepti Chaturvedi, Helen M. Poppleton, Teresa Stringfield, Ann Barbier, Tarun B. Patel posted to rsk pka by guhjy on 2009-11-22 06:26:58 as
	Ras and Nox: Linked signaling networks? [My Copy] Free radical biology & medicine, Vol. 47, No. 9. (1 November 2009), pp. 1276-1281. by Ru Feng F. Wu, Lance S. Terada posted to ras nox by guhjy on 2009-11-22 06:26:41 as
	The PKARIÎ± Subunit of Protein Kinase A Modulates the Activation of p90RSK1 and Its Function [My Copy] Journal of Biological Chemistry, Vol. 284, No. 35. (28 August 2009), pp. 23670-23681. by Deepti Chaturvedi, Michael S. Cohen, Jack Taunton, Tarun B. Patel posted to rsk pka by guhjy on 2009-11-22 06:25:22 as
	RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. [My Copy] Molecular cell, Vol. 35, No. 4. (28 August 2009), pp. 511-522. by Ulrik Doehn, Camilla Hauge, Scott R. Frank, et al.Claus J. Jensen, Katarzyna Duda, Jakob V. Nielsen, Michael S. Cohen, Jens V. Johansen, Benny R. Winther, Leif R. Lund, Ole Winther, Jack Taunton, Steen H. Hansen, Morten Frödin posted to rsk ras erk emt 1 by guhjy on 2009-11-22 06:21:17 as
	Effect of Astilbin on Experimental Diabetic Nephropathy in vivo and in vitro. [My Copy] Planta medica, Vol. 75, No. 14. (November 2009), pp. 1470-1475. by Gui-Sheng S. Li, Wang-Lin L. Jiang, Xi-Dian D. Yue, et al.Gui-Wu W. Qu, Jing-Wei W. Tian, Juan Wu, Feng-Hua H. Fu posted to pt hk2 hg herb by guhjy on 2009-11-22 06:15:09 as
	Phosphatidylinositol 3-kinase/Akt pathway regulates TGF-beta signaling by de-stabilizing Ski and inducing Smad7. [My Copy] The Journal of biological chemistry (29 October 2009) by Arja M. Band, Mia Björklund, Marikki Laiho posted to tgfb smad7 ski pi3k akt 1 by guhjy on 2009-11-22 06:14:00 as along with 1 person Terkko
	Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-beta signaling. [My Copy] Biochimica et biophysica acta (22 October 2009) by Timothy D. Cummins, Michelle T. Barati, Susan C. Coventry, Sarah A. Salyer, Jon B. Klein, David W. Powell posted to tgfb qms pt ms dn by guhjy on 2009-11-22 06:13:03 as
	Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. [My Copy] Transplantation, Vol. 87, No. 2. (27 January 2009), pp. 233-242. by Francesco P. Schena, Michael D. Pascoe, Josefina Alberu, et al.Maria del Carmen Rial, Rainer Oberbauer, Daniel C. Brennan, Josep M. Campistol, Lorraine Racusen, Martin S. Polinsky, Robert Goldberg-Alberts, Huihua Li, Joseph Scarola, John F. Neylan, Sirolimus CONVERT Trial Study Group posted to rt rct rapamycin csa by guhjy on 2009-11-22 06:00:54 as
	Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus. [My Copy] American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, Vol. 9, No. 11. (November 2009), pp. 2552-2560. by A. Servais, V. Meas-Yedid, O. Toupance, et al.Y. Lebranchu, A. Thierry, B. Moulin, I. Etienne, C. Presne, de Ligny e. . L. B. Hurault, P. Le Pogamp, Y. Le Meur, D. Glotz, C. Hayem, Olivo C. Marin, E. Thervet posted to rt rct rapamycin csa by guhjy on 2009-11-22 06:00:38 as
	Transplantation: To convert or not to convert: lessons from the CONVERT trial. [My Copy] Nature reviews. Nephrology, Vol. 5, No. 7. (July 2009), pp. 371-373. by Suphamai Bunnapradist, Flavio Vincenti posted to rt rct rapamycin by guhjy on 2009-11-22 05:56:21 as
	Proteinuria after conversion to sirolimus in kidney transplant recipients: impact of pre-existing proteinuria, graft function, and angiotensin-converting enzyme inhibitors/angiotensin-receptor antagonists. [My Copy] Clinical transplantation (18 November 2009) by Christian Marx, Martin Busch, Undine Ott, Jens Gerth, Gunter Wolf posted to rt rapamycin proteinuria acei by guhjy on 2009-11-22 05:55:21 as
	The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents. [My Copy] Targeted oncology, Vol. 4, No. 2. (April 2009), pp. 135-142. by Kamalesh Sankhala, Alain Mita, Kevin Kelly, Devalingam Mahalingam, Francis Giles, Monica Mita posted to rt rapamycin 1 by guhjy on 2009-11-22 05:53:37 as
	mToR inhibitors-induced proteinuria: mechanisms, significance, and management. [My Copy] Transplantation reviews (Orlando, Fla.), Vol. 22, No. 2. (April 2008), pp. 125-130. by Emmanuel Letavernier, Christophe Legendre posted to rt rapamycin proteinuria 1 by guhjy on 2009-11-22 05:51:43 as
	Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation. [My Copy] Transplant international : official journal of the European Society for Organ Transplantation, Vol. 22, No. 7. (July 2009), pp. 681-687. by Josep M. Campistol, Paul Cockwell, Fritz Diekmann, et al.Donato Donati, Luis Guirado, Gustaf Herlenius, Dujanah Mousa, Johann Pratschke, Juan Carlos Ruiz C. San Millán posted to rt rapamycin by guhjy on 2009-11-22 05:50:04 as
	Sirolimus to replace calcineurin inhibitors? Too early yet. [My Copy] Lancet, Vol. 373, No. 9671. (11 April 2009), pp. 1235-1236. by Paolo Cravedi, Piero Ruggenenti, Giuseppe Remuzzi posted to rt rapamycin csa 1 by guhjy on 2009-11-22 05:49:59 as
	Sirolimus: Defining Nephrotoxicity in the Renal Transplant Recipient [My Copy] Clin J Am Soc Nephrol, Vol. 2, No. 2. (1 March 2007), pp. 198-199. by Stephen J. Tomlanovich, Flavio Vincenti posted to rt rapamycin by guhjy on 2009-11-22 05:49:29 as along with 1 person brainsman2000
	Transplantation: time to rethink immunosuppression by mTOR inhibitors? [My Copy] Nature reviews. Nephrology, Vol. 5, No. 11. (November 2009), pp. 611-612. by Marcus D. Säemann, Giuseppe Remuzzi posted to rt rapamycin by guhjy on 2009-11-22 05:49:03 as
	Sirolimus in kidney transplantation indications and practical guidelines: de novo sirolimus-based therapy without calcineurin inhibitors. [My Copy] Transplantation, Vol. 87, No. 8 Suppl. (27 April 2009) by Stuart M. Flechner posted to rt rapamycin csa by guhjy on 2009-11-22 05:37:05 as
	Our approach to a renal transplant biopsy. [My Copy] Journal of clinical pathology (22 October 2009) by Rohan John, Andrew M. Herzenberg posted to rt pathology by guhjy on 2009-11-22 05:31:47 as
	Mechanisms and management of proteinuria in kidney transplant patients. [My Copy] Drugs, Vol. 68 Suppl 1 (2008), pp. 33-39. by Azemi A. Barama posted to rt rapamycin proteinuria by guhjy on 2009-11-22 05:31:41 as

Note: You may cite this page as: http://www.citeulike.org/user/yavanna/watchlist

Result page: 1 2 3 4 5 6 7 8 9 10 Next

file-import-08-07-27	31
macrophages	24
animals	21
kidney	20
mice	20
cell	16
cells	13
chemokine	12
humans	11
inbred	11
inflammation	11
liver	10
obesity	10
tumor	10
aki	9
diabetes	9
necrosis	9
c57bl	8
clinical	8
proteins	8
receptors	8
tissue	8
transgenic	8
adipose	7
ccl2	7
coculture	7
fatty	7
insulin	7
knockout	7
line	7
male	7
signal	7
techniques	7
atherosclerosis	6
communication	6
cultured	6
di	6
diabetic_nephropathy	6
factor-alpha	6
factors	6
insulin_resistance	6
lithium	6
macrophage	6
metabolism	6
monocytes	6
receptor	6
resistance	6
transduction	6
acids	5
apoptosis	5
biomarker	5
ccr2	5
cx3cr1	5
expression	5
factor	5
gene	5
hepatocytes	5
kupffer	5
mn	5
stem_cell	5
4	4
adipocytes	4
b	4
chemokines	4
ckd	4
cxcl10	4
dietary	4
fats	4
female	4
hypertension	4
ivig	4
mellitus	4
metabolic	4
nephrology	4
nonesterified	4
podocyte	4
ppar	4
regulation	4
snail	4
toll-like	4
2	3
acid-base	3
adiponectin	3
annual2004	3
cardiac_rehabilitation	3
chemotaxis	3
cxc	3
dialysis	3
differentiation	3
disease	3
emt	3
fibrosis	3
genetic	3
glucose	3
gsk3	3
hemodialysis	3
hhs	3
hmgb1	3
interleukin-1	3
interleukin-6	3
ischemiareperfusion	3
leukocyte	3
metabolic_acidosis	3
metabolic_syndrome	3
method	3
mirna	3
nf-kappa	3
nuclear	3
obese	3
paracrine	3
prognosis	3
proliferation	3
review	3
rna	3
syndrome	3
triglycerides	3
type	3
uti	3
weight	3
x	3
acid	2
adaptor	2
aliskiren	2
anca	2
and	2
arteriosclerosis	2
biological	2
body	2
bone	2
c3h	2
carcinoma	2
cd14	2
clamp	2
cx3cl1	2
cxcr3	2
cytokines	2
cytoplasmic	2
diseases	2
dose-response	2
drug	2
er_stress	2
foam	2
fractalkine	2
gamma	2
genetics	2
hearing-loss	2
heart_failure	2
hepatocellular	2
hepatocyte	2
hypertrophy	2
isolated_acth	2
japan	2
kdoqi	2
lipid	2
lipopolysaccharides	2
lorazepam	2
mcp-1	2
mechanism	2
membrane	2
messenger	2
mpa	2
mutant	2
neoplasms	2
of	2
p38-mapk	2
peritoneal	2
progression	2
propylene_glycol	2
proto-oncogene	2
rats	2
recombinant	2
relationship	2
renin	2
research	2
rnai	2
shp	2
stem	2
strains	2
suganami	2
tlr4	2
t-lymphocytes	2
transcription	2
transfection	2
transgenes	2
transport	2
up-regulation	2
vegf	2
woodhouse-sakati	2
1	1
11beta-hsd1	1
3t3	1
3t3-l1	1
5q-_syndrome	1
88	1
9	1
a2b	1
abdominal_surgery	1
abx	1
acetaminophen	1
acid-binding	1
actin	1
activation	1
activator	1
acute	1
adenoviridae	1
adipocyte	1
adipokine	1
age	1
aged	1
agents	1
airway	1
alanine	1
amiloride	1
ampk	1
analgesics	1
analysis	1
antibodies	1
antigens	1
antimetabolites	1
antimicrobial	1
anti-obesity	1
aps	1
aquaporin-2	1
aristolochic_acid	1
array	1
artery	1
assay	1
at2r	1
atra	1
bac_transgenic	1
bad	1
balb	1
barrier	1
benzophenones	1
beta	1
beta-catenin	1
bile	1
binding	1
black_swan	1
blocking	1
blood	1
blood_pressure	1
blotting	1
bone_marrow	1
bronchoconstriction	1
brown	1
c	1
c-akt	1
calcification	1
capd	1
carbon	1
carboxykinase	1
cardiovascular	1
carotid	1
carrier	1
carter	1
cationic	1
cattle	1
c-bcl-6	1
ccr5	1
cd11c	1
cd16	1
cd44	1
cell-cycle	1
cholesterol	1
chorea	1
cilia	1
circulation	1
cirrhosis	1
common	1
complement	1
complementary	1
conditioned_medium	1
cox2	1
creatinine	1
cre_loxp	1
cross-talk	1
cryoglobulin	1
cutaneous	1
cxcl9	1
cxcr4	1
cyclooxygenase	1
cyclophosphamide	1
cyclosporin	1
cyst	1
cytokine	1
cytoskeleton	1
dba	1
deoxyglucose	1
depletion	1
derma	1
development	1
diazepam	1
diet	1
distribution	1
dna	1
dna-binding	1
down-regulation	1
duct	1
dyspnea	1
eicosapentaenoic	1
empiric	1
endocrine	1
endocytosis	1
endothelial_cell	1
energy	1
enzyme-linked	1
ep4	1
epo	1
eps	1
escape_trial	1
et-1	1
experimental	1
facs	1
factor-kappa	1
failure	1
fetuin-a	1
ffa	1
food	1
formulated	1
fusion	1
g12-g13-larg	1
gain	1
gain_of_function	1
ganglia	1
gdp	1
gensalt	1
gland	1
glucose-6-phosphatase	1
glycoproteins	1
growth	1
gtp	1
h	1
haloperidol	1
hba1c	1
hemorrhagic	1
hepatic_fibrosis	1
heterogeneity	1
hitopathology	1
hmcp-1-7-nd	1
ho-1	1
homeostasis	1
homing	1
hormones	1
hybridization	1
hydrolases	1
hyperkalaemia	1
hyperlipidemias	1
hypokalaemia	1
hypoparathyroidism	1
hypotension	1
hypothyroidism	1
i	1
icr	1
iddm	1
idiopathic_glomerular_disease	1
ii	1
ikkbeta	1
immunity	1
immunosorbent	1
immunosuppression	1
in	1
indication	1
infection	1
injections	1
injury	1
interferon	1
interleukin-8	1
interstitial_nephritis	1
intestinal	1
intraperitoneal	1
ir	1
iron	1
islets	1
jewel	1
jewels	1
jnk	1
kidney_biopsy	1
langerhans	1
leishmania	1
leishmaniasis	1
leptin	1
ligand	1
ligands	1
ligation	1
lipids	1
lipolysis	1
lna	1
lung	1
lxr	1
m2	1
magnetic	1
major	1
mapk	1
markers	1
marrow	1
matrix	1
mediators	1
medical_science	1
metalloproteinase	1
middle	1
mitochondrial	1
monoclonal	1
monocyte	1
movement	1
mpgn	1
mrna	1
mucosa	1
mutation	1
myeloid	1
myoblasts	1
nash	1
ncrna	1
nephrosclerosis	1
nephrotic_syndrome	1
neutralization	1
neutrophils	1
nfkb	1
nod	1
non-narcotic	1
ocular	1
oligonucleotide	1
organ	1
osteoclast	1
ota	1
palmitic	1
paradox	1
pathology	1
pd	1
peptide	1
peptides	1
phenotype	1
phosphoenolpyruvate	1
phosphorylation	1
physical_exam	1
pkd1	1
placebo	1
pnmrs	1
polii	1
ppar-	1
predisposition	1
primary_care	1
proinsulin	1
promoter	1
protein	1
protein_c	1
pth	1
rank	1
rapid_onset	1
raw264	1
rct	1
regeneration	1
regions	1
regulatory	1
renal_failure	1
renal_fibrosis	1
repair	1
reperfusion	1
repressor	1
rho	1
rifle	1
risk	1
risperidone	1
rituximab	1
rock	1
rosubastatin	1
saa	1
salicylate	1
salt	1
salt-sensitivity	1
screening	1
sdf-1	1
sedation	1
sepsis	1
sequence	1
shock	1
signalling	1
simvastatin	1
situ	1
size	1
skeletal	1
sleleton	1
smooth_muscle	1
sonography	1
spot_urine	1
sprague-dawley	1
steroid_treatment	1
stress	1
stroke	1
surface	1
technique	1
tests	1
tetrachloride	1
tgf-1	1
tgf-beta	1
thiazoles	1
thyroglobulin	1
thyroid	1
time	1
tlr	1
to	1
training	1
tranilast	1
transaminase	1
transducing	1
transformation	1
transforming	1
transplantation	1
tropomyosin	1
tubular	1
tyrosine	1
ubiquitination	1
upar	1
urine_culture	1
uuo	1
vectors	1
vesicular	1
visualizing	1
vit_d_knockout	1
western	1
white	1
women	1
y-27632	1

yavanna's watchlist [more than 800 articles] Export

yavanna's tags